CORONA Remedies Limited has submitted a regulatory filing to BSE Limited and the National Stock Exchange of India Limited intimating a scheduled meeting between company officials and analysts/investors.
The disclosure is made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
Meeting Details
- Day, Date & Time: Wednesday, September 23, 2026 at 2:00 pm
- Organized By: JP Morgan
- Nature of Meeting: Group Meeting
- Place: Ahmedabad
Key Disclosures
- Discussions during the meeting will be based solely on publicly available information.
- The company explicitly states that no unpublished price sensitive information (UPSI) is intended to be discussed during these interactions.
- The intimation notes that changes to the schedule may occur due to exigencies on the part of either the host (JP Morgan) or the company.
Additional Information
This intimation has been made available on the company's website at www.coronaremedies.com.
The letter is digitally signed by Chetna Prabhat Kumar Dharajiya, Company Secretary and Compliance Officer of CORONA Remedies Limited, on September 18, 2026, at 14:49:59 IST.